NCT04056104View on ClinicalTrials.gov

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

NACompletedINTERVENTIONAL
Enrollment

543

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

December 12, 2021

Study Completion Date

December 12, 2021

Conditions
Congenital Heart Disease
Interventions
DIAGNOSTIC_TEST

SpO2 and PIx Measurement

Right upper and any lower extremity oxygen saturation (SpO2) and perfusion index (PIx) will be measured

Trial Locations (6)

11040

Northwell Health, New Hyde Park

84113

University of Utah/Primary Children's Hospital, Salt Lake City

90095

David Geffen School of Medicine at UCLA, Los Angeles

94158

UCSF Benioff Children's Hospital, San Francisco

95816

Sutter Institute for Medical Research, Sacramento

95817

University of California-Davis, Sacramento

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of California, Davis

OTHER

NCT04056104 - Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements | Biotech Hunter | Biotech Hunter